You are here: All Products  > Hansoh In-licenses Novel BCR-ABL Inhibitor for CML in $68 Million Agreement

Hansoh In-licenses Novel BCR-ABL Inhibitor for CML in $68 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products